Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Your Pharma Contract Is Approved. But Is It A Competitive Deal?
Nithin Mummaneni is the founder and CEO of Infinity Loop. A 300-page pharmaceutical outsourcing agreement can clear legal, quality, regulatory and technical review without anyone asking whether the price is competitive. Each department…
ASX Runners of the Week: Black Rock, Mayne Pharma & Metal Hawk
There's only one word to describe markets this week… Carnage. As of mid-market Friday, the ASX is in the midst of its seventh straight losing session, a plunge of more than six per cent that has now wiped out every cent of its 2026 gains. It…
Scoop: Pharma marketing startup Doceree seeking $100M in growth capital
Axios Pro Exclusive Content 28 mins ago…
Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines
NEW YORK/LONDON, Nov 20: Artificial intelligence has sped up early-stage drug development work at some of the world's largest pharmaceutical companies this year, cutting by as much as half the time it takes to produce new molecules and move them…
3 Big Pharma Dividend Stocks Built for Retirement Income
A retirement portfolio needs income that holds up through patent cliffs, and the world's largest drugmakers have spent decades replacing old blockbusters with new ones while the dividend checks keep coming. Bristol Myers Squibb (NYSE:BMY | BMY…
Avalyn Pharma Inc. (NASDAQ:AVLN) Stock Has Consensus Price Target of $59.20
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) has been given an average rating of 'Moderate Buy' by the seven brokerages that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell…
Royalty Pharma PLC $RPRX Stock: Voya Investment Management LLC Boosts Position
Voya Investment Management LLC grew its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 104.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned…
Avalyn Pharma (NASDAQ:AVLN) Insider Sells 13,300 Shares of Stock
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) insider Howard Lazarus sold 13,300 shares of the business's stock in a transaction on Tuesday, November 17th. The shares were sold at an average price of $27.90, for a total transaction of…
Spyglass Pharma (NASDAQ:SGP) Shares Gap Down - Here's Why
Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) shares gapped down prior to trading on Thursday. The stock had previously closed at $31.43, but opened at $29.73. Spyglass Pharma shares last traded at $28.47, with a volume of 5,982 shares…
Pharmalittle: We're reading about a Merck AI deal, China and the pharma supply chain, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us. As for the official mascots, they have finished keeping…
Urogen Pharma (NASDAQ:URGN) Stock Price Up 6.8% - Still a Buy?
Urogen Pharma (NASDAQ:URGN - Get Free Report)'s stock price rose 6.8% on Thursday. The company traded as high as $31.83 and last traded at $31.8150. 317,146 shares were traded during mid-day trading, a decline of 64% from the average daily volume…
Nuvectis Pharma (NASDAQ:NVCT) Shares Gap Up - Should You Buy?
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report)'s share price gapped up prior to trading on Thursday. The stock had previously closed at $19.20, but opened at $20.48. Nuvectis Pharma shares last traded at $20.2750, with a volume of 7,363…
UBS to offshore hundreds of roles to India
The offshoring push is part of a long-term strategy plan to move roles away from higher-cost European locations, according to people familiar with the matter. UBS's group functions include finance, operations, risk control, compliance, legal and…
Sanofi's New CEO Eyes Mega-Deal to Jump-Start Pipeline Rebuild
Sanofi SA underwhelmed investors when it appointed Belen Garijo as chief executive officer this year. Just over six months into her tenure, she's considering the biggest pharma deal in years to help do exactly what shareholders have demanded: fix…
A case for studying pure chemistry
Chemistry is one of the oldest fields that have flourished over the past two and a half centuries since the discovery of oxygen by Antoine Lavoisier in 1777. In the early stages, physics and chemistry shared similarities in concepts. Then slowly…
Receive a Daily briefing on Pharma Industry News
Get Started